Complications of bone marrow transplantation can compromise its effectiveness, and often it is not possible to predict who is at greatest risk. In a previous study we reported that certain psychological factors correlated with a high incidence of post-transplant mortality, and here we analyze the associated complications and causes of death. Prior to receiving high-dose chemotherapy and bone marrow transplantation, 112 patients underwent a psychodynamically oriented psychiatric assessment (the 'FIT' assessment). Mortality and associated complications were ascertained by a retrospective chart review. The results of the 'FIT' assessment correlated with the incidence of complications and death, whether or not the transplant was performed for hematologic or solid organ cancers, or was from an allogeneic or autologous source. Most individuals with a high risk profile died of progressive major organ dysfunction or recurrent/refractory neoplastic disease in the first year after transplant. We propose that such a psychiatric assessment might identify a subgroup of individuals in whom pre-emptive therapeutic interventions could be most effective.
was any attempt made to associate a parameter of psychological functioning with post-transplant survival. Later, Futterman et al 6, 7 developed a rating scale that predicted 'emotional complications' and length of hospital stay, while others, using a variety of instruments, suggested that certain parameters (eg 'depressed mood'; 'anxious preoccupation') might relate to prognosis. [8] [9] [10] However, we are not aware of any published investigations that have used psychodynamic methods to prospectively link personality characteristics with patterns of medical complications and transplantrelated mortality. This paper extends previous observations that life-long personality traits correlate with survival in the first years after bone marrow transplantation. 11 Analysis of the clinical course of individuals in this cohort suggests that those with a high risk psychological profile underwent early complications that led to their demise due to multiorgan failure or recurrence of their cancer.
Materials and methods

Patient population
From 1984 to 1993, 120 individuals underwent bone marrow transplantation at the Royal Victoria Hospital. Excluded from analysis were two subjects transplanted before psychiatric evaluation, three who refused, and three who either were lost to follow-up or date of death could not be documented. Analysis of survival was based on data from these 112 subjects, and after exclusion of two others because of lost hospital charts, analysis of complications was performed on the remaining 110. The baseline characteristics are summarized in Tables 1 and 2 .
Psychiatric assessment
The inter-relationships among the individual components of the psychiatric examination, as well as documentation of concurrence between different interviewers have been described elsewhere. 11 A psychiatric assessment was considered part of the routine pre-transplant evaluation, and ongoing psychiatric care was included as part of the routine post-transplant management. Information resulting from the initial evaluations was structured and recorded in a semi-quantitative form (the 'FIT assessment') in an attempt to standardize the acquisition of psychiatric clinical data; confidentiality of information was maintained. Although the consulting psychiatrist (LH) inevitably was aware of the cancer diagnosis, he was not informed of medical details (eg cytogenetics, leukemia cell phenotype, lymph node status) that might bias assessment.
In the course of two to three psychodynamically oriented psychiatric interviews, a single psychiatrist evaluated three aspects of the individual's personality, which included their functioning within the family unit (F parameter), their individual psychological maturity (I parameter), and their capacity to form and communicate a mature psychological construct of the transplant/treatment process (T parameter). This led to the 'FIT rating' according to which each parameter was assigned a score ranging from 1 (lowest) to 3 (highest), with a possible total of 3-9. Interviews usually took place in the outpatient clinic during the waiting period between acceptance into the program and hospital admission to begin the pre-transplant conditioning regimen. None of the patients was receiving chemotherapy at the time.
Family functioning: the 'F' parameter: This first parameter assessed the family's rules, roles and myths in order to evaluate its unique 'culture' and flexibility. The goal was to ascertain how the transplantee perceived his family to function and what might be his relationship to it. 12 Of dimensions that describe family function, two span the extremes of enmeshment to disengagement and rigidity to chaos; [13] [14] [15] [16] [17] an 'ideal' balance would be where consistency and respect for individual autonomy include sufficient flexibility to allow timely adjustment of roles, interactions and boundaries. In sum, the interview aimed to assess these life-long attributes to answer the question, 'To whom does the transplant belong?'
For example, the high functioning family (score = 3) would allow the transplantee to make her own decision whether or not to undergo a transplant, and would respect her decision even if the other members were to disagree. In the intermediate functioning family (score = 2), the transplantee ultimately would make his own decision, but would be concerned that it would have a negative impact on the others. In the low functioning family (score = 1), the transplant appears to belong to the entire group, and therefore the transplantee does not have any choice but to submit to the collective decision.
Individual psychological maturity: the 'I' parameter:
The second parameter is a global assessment of an individual's psychological functioning derived from an evaluation of defense mechanisms, quality of relationships, and patterns and expression of affect. Based upon life-long personal history and psychological structure, it assessed integrated traits, and not simply the state at one point in time. In this context, the manner in which an individual reacts to illness (or pending BMT) reflects the level of psychological maturity, and need not be masked by coping strategies related to the immediate stress.
The concepts of defense mechanism, object relations and affect are well established in the psychiatric and psychoanalytic literature, theory, and practice. First categorized by Sigmund Freud, 18 and later expanded by Anna Freud, 19 Kernberg, 20 and Klein, 21 defense mechanisms are defined as the unconscious and habitual mental processes that attempt to resolve conflicts between impulses, internal prohibitions and external reality. Later, Vaillant 22, 23 observed overt behaviors that reflected multiple intrapsychic processes in order to examine ego function in operational terms. He and others have demonstrated that the 'maturity' of an individual's defenses correlated with objective adaptations to the external world, which when inadequate led to overt psychopathology. [22] [23] [24] [25] [26] Here, we used an adaptation of Vaillant's scale developed by the Individual and Group Psychotherapy Unit of the Allan Memorial Institute/Royal Victoria Hospital 27 as the basis for this component of the assessment.
The quality of relationships (object relations), as used here, is the sense of uniqueness, separateness, and individuality perceived by the self, and is expressed by the ability to relate to others as separate from self. By examining present relationships with important persons in the context of significant past relationships, it is possible to infer certain characteristics of that person in both the external and intrapsychic worlds. Affect examines the quality of emotion as well as its appropriateness for a particular individual in a particular situation or relationship. Further attention is directed to feelings and experiences of previous illnesses and medical intervention. Likewise, the responses to previous illness, losses and success, both within and outside the medical context, provide an indication of established patterns and provide a basis for possible extrapolation.
The high functioning individual (score = 3). These individuals tend to use the defenses of sublimation, suppression, anticipation, humor and altruism. Their relationships show clear evidence of stability, and are based upon the notion that one is autonomous, intact, and separate, yet emotionally attached to the 'significant' other. The range of affect appropriately corresponds to subjective experiences. In times of stress, conflicting feelings can be recognized and accepted or tolerated with the belief that their significant object relationships will remain intact. Such high functioning individuals are sufficiently secure in themselves and others to be flexible in coping with strange or frightening situations.
The intermediate functioning individual (score = 2). Although they can employ defense mechanisms of the higher level under stable conditions, or decompensate to poorer function under stress, individuals of intermediate function tend to rely on reaction formation, intellectualization, repression, isolation and intermittent regression. They attempt to maintain external relationships by establishing and performing a stable role, alternately viewing others as being self or separate and autonomous. While fearing loss of a relationship, they strive to control it by attempting to placate and please, yet feel anxiety, frustration, anger and competition as the result. The individual of intermediate function experiences the world through a restricted repertoire of affects, which may be inappropriate both in quantity and quality for any particular internal experience or external event. In relationships, they have a variable capacity to experience and acknowledge conflicting affects concerning a person or event. Although they appear to be at ease with interpersonal relationships, they find it difficult to engage and trust.
The low functioning individual (score = 1). These individuals use predominantly defense mechanisms rated as fair and poor by Vaillant. Fair defense mechanisms include projection, denial through phantasy, introjection, passive aggression, acting out, and turning against self; poor defense mechanisms are considered to be splitting projection, massive denial, massive distortion, and depersonalization. Relationships of low function are characterized by instability with little differentiation between self and other. Other individuals are experienced as being there to supply basic needs, or to contain anxiety around issues of separation. Attempts to reach out usually end in disappointment and withdrawal. When relationships do form, they are predominantly dependent and dominated by feelings of helplessness, or are controlling, coercive, and permeated with rage at unfulfilled demands. Preoccupation with object loss, abandonment, and retribution prevent development of mutual love between equals. Likewise, the affect of these individuals is equally disconnected from external events and objects, often of an intensity not appropriate for the situation or event.
Attitude toward transplant/treatment: the 'T' parameter: This parameter assesses an individual's ability to formulate a psychologically sound construct of the bone marrow transplant. The capacity to imagine him/herself undergoing the procedure, as well as the readiness to discuss its potential complications and consequences, including the positive and negative aspects, all reveal the extent to which a person can acknowledge the transplant as a unique event. Ultimately, this answers the question of what the BMT represents intra-psychically to that individual; an opportunity to discover and grow, a repetition of past conflicts, or an unavoidable punishment and attack.
Attitude of high functioning (score = 3). Characteristic of candidates within the high group is their view of the transplant as a unique and individual experience: 'I will do the transplant because . . .' Generally, they enter into the assessment process in a mutually exploring manner, and although they may question its usefulness initially, they are open to it. Indeed, they even may seek out an opportunity to discuss their feelings, stresses and fears. Although such individuals may have had their life's agendas diverted, and may question and disagree with medical opinions and treatment procedures, they do not see the transplant as an attacker or annihilator. Overall, they are able to entertain the reasoning of the staff, and balance the inevitable ambiguities in the context of a mutually respectful exchange. Individuals in this group are able to construct their own concept of the transplant and the transplant space, and can constantly modify it as new information is provided, as treatment is experienced, and as particular attitudes are explored and comprehended. They are able to entertain the positive and negative aspects of the procedure as relating to themselves, and can recognize it as belonging to them, with individual medical and psychological meaning.
Attitude of intermediate functioning (score = 2). Ambivalence characterizes the perception of individuals in this group: 'I could try to have the transplant if . . .' They tend to begin the assessment process with mixed feelings, yet eventually are willing to express their thoughts and concerns. Often, their approach to the transplant is perceived to be a task to bear for someone else (eg family, physician) or for an external cause (eg medical research). Although they may share their notions about the theoretical aspects of the procedures, they are reluctant to explore what they imagine will happen to them during the transplant. As compliant patients, they generally cooperate with ward routines, but often try to ignore the unpleasant aspects of the transplant and avoid any discussion of them. At other times they are able to identify the transplant as something happening to them, are able to discuss its positive and negative aspects, and may even formulate their own psychological construct of their potential transplant experience.
Attitude of low functioning (score = 1). Denial and resignation characterize the base from which these individuals form their construct of the transplant: 'It must happen to me.' They respond to the preparations in a disengaged, affectless, and often pseudo-compliant/pseudo-cooperative manner, and without questioning will do whatever is required of them by the physicians and nursing staff. Although consent forms are signed, protocol literature is accepted, appointments made, and meetings kept, they are not able to recall the details of discussions and information given. Although they may make a cursory visit to the transplant area, they avoid active information-gathering. Such individuals assume that the system will benevolently, protect, restore and repair them. Surrendering themselves to an idealized omnipotent physician, they do not acknowledge any need to be informed and consider only the positive aspects of the transplant experience; 'My doctor knows what is best for me.' These individuals constantly attempt to protect themselves against the overwhelming anxiety related to the terror of annihilation by the transplant. An attempt to explore these issues can precipitate rage and accusations of mistreatment. They then may acknowledge that they experience the transplant as a punitive ordeal to which they must submit. If initial idealization gives way to devaluation of the experience, 'acting out' behaviors may occur (eg meetings are canceled or 'forgotten'), and issues of non-compliance with medical treatment may arise. These individuals are not able to formulate a psychological construct of their transplant.
Bone marrow transplantation protocols
Transplant donors included three identical twins; all allogeneic transplants were from HLA matched siblings, except for three from a sibling sharing one haplotype. Conditioning regimens prior to transplant included the following: carcinoma of breast (n = 32) -mitoxantrone, cyclophosphamide, cis-platinum, melphalan (25) , or cyclophosphamide, cis-platinum, BCNU (6), or cyclophosphamide, cis-platinum, thio-tepa (1) Bone marrow alone was administered after the conditioning regimen in 98, peripheral blood stem cells in five, and both in seven. Prevention of graft-versus-host disease (GVHD) prior to 1987 consisted of ex vivo T cell depletion with T101-conjugated ricin in 13/16; in 3/16, as well as those transplanted after mid-1987, prevention protocols employed methotrexate and cyclosporin. Standard modalities of care for transfusion support, fluid management, nutrition, and antibiotic coverage for prevention and treatment of infection were maintained uniformly within the population.
Analysis of complications
At least 2 years after transplant, the hematologist co-investigator (AKS) performed a chart review of each patient. Details of the psychiatric interviews (including the 'FIT' assessment) were not known to either the treating team or the collaborating hematologist (AKS) until the period of data acquisition had passed. The retrospective analysis and correlation with psychiatric data were approved by the ethical review board of the Royal Victoria Hospital. The scale described by Bearman et al 28 was used to quantify the organ toxicities. Briefly, cardiac, bladder, renal, pulmonary, hepatic, CNS, GI, and stomatitis toxicities were assigned a grade of 1-3 in increasing severity; death from a given complication was assigned a grade of 4. In addition, categories were added to the Bearman scale to include GVHD, infectious, hemorrhagic, and metabolic complications, also with a grade of 1-4 (Table 3) ; GVHD was graded according to Deeg et al. 29 For each individual, the sum of the highest toxicity in each category constituted the total 'toxicity score'.
The period of neutropenia was defined as the number of days between transplant and attainment of a neutrophil count (ANC) of 0.5 ϫ 10 9 /1 for 2 consecutive days. The period of thrombocytopenia was the number of days between transplant and attainment of a platelet count of 30 ϫ 10 9 /1 for 2 consecutive days, unsupported by transfusion for the previous 48 h.
As an index of sustained hypoalbuminemia, the 'albumin deficit' was calculated from the area under a curve demarcated by changes in the serum albumin concentration obtained at various time points, subtracted from the area that would have resulted if the value had remained constant (eg if the value did not change, the deficit would be 0). The time points were: (1) within the week prior to the conditioning regimen, (2) the day of transplant, and (3-
Statistical analysis
Differences between the survival curves were analyzed by the logrank test. Differences in blood cell counts and toxicity scores were assessed by the Kruskal-Wallis nonparametric ANOVA test. Other analyses were according to the tests noted in the figure legends. 30 Tests for statistical significance were performed as indicated in each individual analysis; computations were performed using the statistical package GraphPad PRISM-Version 2.0 (GraphPad Software, San Diego, CA, USA). For multivariate analysis using the Cox regression model, the Statistical Package for the Social Sciences was used. The designation 'not significant' (NS) is applied when the related P value was greater than 0.05.
Results
Patient characteristics
All patients except for five had a Karnofsky performance status of Ͼ90% when admitted for transplant. As indicated by the pre-transplant serum albumin concentration, all groups were of equivalent nutritional status (FIT 3 = 38 Ϯ 5.7 (s.d.); FIT 4 = 38 Ϯ 5.4; FIT 5/6 = 38 Ϯ 5.6; FIT 7/8/9 = 40 Ϯ 4.1; P = NS, ANOVA). Of 20 subjects with acute leukemia (ALL = 8; AML = 12), 13/20 were in complete remission (CR) and 7/20 in second remission, partial remission, or relapse. Of nine subjects with CML, seven were in chronic phase, one in accelerated phase, and one in blastic transformation.
Relation of survival to psychological factors
By 1 year after transplant the overall survival was Ͼ50% (Figure 1a) . However, when the population was subdivided according to the described psychological factors, all individuals with a FIT assessment of 3 had died by day 300 (median = 51 days), and 90% of those with a FIT 4 had died before 1 year (median = 185 days). In contrast, 90% of patients who had a FIT assessment of 5-9 survived longer than 1 year.
This cohort of patients was heterogeneous in that marrow 112) . By the log rank test, the curve for the FIT3 group differs from FIT4 (P = 0.0007); FIT4 vs FIT 5/6 (P Ͻ 0.0001); FIT5/6 vs FIT7/8/9 (NS). (b) Pattern for 89 patients after those with advanced leukemia, a Karnofsky score Ͻ90% at the time of transplantation, and a previous psychiatric history had been excluded. By the log rank test, the curve for the FIT3 group differs from FIT4 (P Ͻ 0.005); FIT4 vs FIT5/6 (P Ͻ 0.0001).
was transplanted from both allogeneic and autologous sources, and the primary diseases included both solid cancers and hematological neoplasms. When survival was analyzed in relation to these parameters, it was shortest for subjects who had received a FIT 3 or FIT 4 rating (Figure 2) . Thus, these psychological factors identified groups of high (FIT3/4) and low (FIT 7/8/9) risk of mortality in the first year. In a multivariate analysis of 25 other major variables in relation to survival, only the source of bone marrow (allo vs auto; P = 0.03) and status of disease (advanced vs not advanced; P = 0.01) attained significance; however, when the FIT rating was included, it far outweighed all others (P Ͻ 0.0001). 
Relation of baseline characteristics to results of the FIT assessment
The distribution of the FIT assessment among disease groups is shown in Table 4 . Of the nine patients with leukemia who were not in first CR or chronic phase, 8/9 had a 'low' and 1/9 an 'intermediate' FIT assessment. Of 20 individuals transplanted in CR or chronic phase of CML, 7/20 had a 'low', 5/20 had an 'intermediate', and 9/20 had a 'high' FIT assessment. Of the five who underwent transplant with a Karnofsky score of Ͻ90%, 4/5 had received a 'low' FIT rating. Eight subjects had a prior psychiatric history, but none suffered an exacerbation of the underlying disorder during the period of isolation. Nonetheless, when the 23 subjects with a high biological risk pretransplant were edited, and the survival of the remaining 89 was analyzed, a FIT assessment of 3 or 4 still correlated with significantly shorter survival in the first year (Figure 1b) .
Relation of psychological factors to recovery of hemopoiesis
For the total population, the mean time to attain an ANC Ͼ0.5 ϫ 10 9 /l was 20 Ϯ 10 (s.d.) days. Of these, 46% had received G-or GM-CSF, and the time of neutropenia was 18 Ϯ 2 (s.e.m.) days, in contrast to 24 Ϯ 2 for those who did not (P = 0.018; two-tailed t-test; eight subjects who died while neutropenic before day 40 excluded). As shown in Figure 3a , however, the median time to attain the target ANC did not differ among the psychological risk groups. The median time to recovery or death was 16, 17 and 18 days for the low, intermediate and high risk groups. Thus, delayed engraftment, as manifested by the peripheral neutrophil count, did not explain the shortened survival of the high risk group.
A similar pattern was noted for platelet recovery. For subjects surviving long enough to attain a count of 30 ϫ 10 9 /l (n = 90), the period of thrombocytopenia was 30 Ϯ 28 (s.d.) days, and the difference among the FIT subgroups was not significant. However, among the FIT 3/4 group was a subpopulation who died while thrombocytopenic, and of these, the period of thrombocytopenia was significantly longer.
Relation of psychological factors and survival to serum albumin
Calculation of the 'albumin deficit' in the first 28 days after BMT identified two groups. The minority with a deficit Ͼ50 had a median survival of 145 days, whereas those with a deficit Ͻ50 did not reach their median survival by the end of 1 year (Figure 4a ). If analyzed according to their FIT assessment, subjects with a deficit Ͻ50 were represented in all psychological risk groups (Figure 4a inset) . However, those with a deficit Ͼ50 were predominantly from the low FIT groups (69% FIT 3/4, 25% FIT 5/6 and 6% FIT7/8/9). Furthermore, the albumin deficit of those who died while thrombocytopenic was significantly higher than those who recovered their platelet counts before death (Figure 4b) .
Relation of psychological factors to complications of transplant
For each individual who underwent the procedure, the complications in selected organs were quantified, and a cumulative score obtained. As shown in Figure 5 , those who had Relation between the albumin deficit, survival and psychological risk factors. (a) Survival curves for subjects having an albumin deficit higher or lower than 50. The 'deficit' is illustrated in the inset below as the noted area in a curve of albumin concentration vs time, as described in the Methods. The difference in survival between subjects with a deficit greater or less than 50 is significant (log rank test, P Ͻ 0.0001). The inset within this graph shows the distribution of values above and below 50 among the different FIT groups. The greatest proportion of individuals with the higher deficit is in the FIT3/4 group ( 2 test, P = 0003). (b) Comparison of the albumin deficit in patients who died while thrombocytopenic in contrast to those whose counts reached the target value. The boxes drawn around the scatter of values span from the 25th to the 75th percentile, with the bar across the median. The deficit is greater in those who remained thrombocytopenic until death (P = 0.005, two-tailed MannWhitney nonparametric test for comparison of means).
received the lowest FIT assessment suffered greater toxicity by 28 and 56 days after transplantation (Figure 5a and b) . Examining the trends for each individual patient, those with a FIT 3 score not only had more severe complications earlier, but the toxicities continued to progress during the second month ( Figure 6 ). This was not related to GVHD; among subjects receiving T cell-depleted marrow, the incidence of grades I-II and III-IV was 6/13 and 1/13, respectively; of the others receiving prophylaxis with methotrexate The occurrence of subjects within each of the noted disease categories among the three FIT groups differs significantly from a random distribution ( 2 ; P Ͻ 0.02). One subject of the 110 died out of hospital and cause of death could not be determined. and cyclosporin, the incidence was 5/15 and 2/15. The incidence did not differ among the FIT groups ( 2 ; P = 0.4). The overall rate of infectious complications is illustrated in Figure 5c , which shows a trend toward a higher frequency in the FIT 3 group. The mean febrile days (у38.0°C, not clearly related to amphotericin or blood products) for individuals in the FIT 3, 4, 5, 6 and 7-9 groups was 19 Ϯ 4 (s.e.m.), 12 Ϯ 4, 11 Ϯ 2, 7 Ϯ 1 and 8 Ϯ 1, respectively, significant only between the FIT 3 and the FIT у6 groups (P Ͻ 0.05, Tukey-Kramer multiple comparisons test). The number of antibiotics used, in addition to those of prophylactic regimens, could indicate unresponsiveness or progression of a presumed or documented infection. The mean number of added antibiotics was 4.3 Ϯ 0.5 (s.e.m.), 2.7 Ϯ 0.4, 2.2 Ϯ 0.3, 2.7 Ϯ 0.4 and 2.1 Ϯ 0.2 for the FIT 3, 4, 5, 6 and 7-9 groups, respectively, significant only between FIT 3 and the other groups (P Ͻ 0.05; Tukey-Kramer test). As a surrogate for gastrointestinal toxicity or infection, the days of antidiarrheal medications were compiled. This ranged from a mean of 5-7, and did not differ among the FIT groups (P = 0.8, ANOVA).
As shown in Figure 5c , the incidence of all bleeding events was greatest among the FIT 3 group. Likewise, metabolic complications, which usually manifested as fluid retention refractory to diuretics, occurred almost exclusively in the FIT 3 group. However, the mean days of diuretic use ranged between 6 and 10 among all groups, and the differences between them were not significant (P = 0.7; ANOVA).
Because some individuals might tend to seek or avoid medical attention, have a different tolerance for pain, or communicate a greater level of anxiety to the medical team, the use of medications for symptom control was assessed. The total days of prescribed anti-emetics ranged between 12 and 17, and did not differ among the FIT groups (P = 0.38, ANOVA). The days on which opioids were administered for pain (meperidine was excluded due to its frequent use in modulation of reactions to amphotericin) ranged between 6 and 10 days, and did not differ among the FIT groups (P = 0.39; ANOVA). Similarly, the requirement for psychoactive medications (sedatives, minor tranquilizers and anti-psychotic agents) did not differ among the groups.
Causes of death
The causes of death are summarized in Table 5 . Within the FIT 3 group, 11/19 patients died of consequences considered to be related to sepsis, manifesting as either multiorgan failure, septic shock, or respiratory failure with an acute respiratory distress syndrome. Overlapping these causes were hemorrhagic events and veno-occlusive disease of the liver, which were the direct causes of demise in four subjects. Four others died of causes directly related to recurrence of their neoplastic disease, three of whom survived beyond 100 days. Within the FIT 4 group, only 2/19 died with sepsis/multiorgan failure, but 6/19 died after lingering respiratory compromise. None suffered a major hemorrhage, one succumbed to hepatic/renal failure due to severe GVHD, and 8/19 (42%) lived long enough to undergo complications of refractory or recurrent cancer. This is in contrast to the patterns shown by individuals in the other groups, of which only 3/71 (4%) died of medical complications unrelated to their primary cancer.
Discussion
In this study of individuals undergoing intensive anticancer chemotherapy and bone marrow transplantation, life-long personality traits correlated with the incidence of complications and the time of survival. Of the 39% who died during the first year, half succumbed to sepsis and/or major organ failure (Table 5) ; of mortality not directly related to recurrent or resistant cancer, major organ failure was the cause in 81%.
These data confirm and extend the work of Haire and collaborators 31 who identified multiorgan failure as the commonest mode of demise in patients undergoing allo- geneic or autologous BMT. Most subjects (10/13) who developed sepsis/multiorgan failure in this study had been identified prospectively within the FIT 3/4 group. Comparison of the trends in the FIT 3 vs the FIT 4 groups shows that the latter survived long enough to encounter recurrence of their neoplastic disease, raising the possibility that they might not have received optimal prior chemotherapy, or that their internal milieu may be more permissive to tumor growth. Current understanding views death from multiorgan failure as the extreme consequence of stresses that induce a systemic inflammatory response syndrome (eg endotoxin, burns, mechanical trauma). [32] [33] [34] Evidence argues that the monocyte/macrophage system processes the inflammatory stimulus, 35, 36 and then initiates and amplifies subsequent cytokine cascades. 37, 38 Under certain conditions, this can lead to loss of control, functional immune paralysis, [39] [40] [41] or in the metaphor of Bone, 42 'immunologic dissonance'-a pathological imbalance between pro-and counter inflammatory molecules. Clinically, signs of the acute respiratory distress syndrome, disseminated intravascular coagulation, 43 hemodynamic collapse, and acute renal failure all indicate deviation from a protective inflammatory response. Under these conditions, the damaged gastrointestinal tract may trap platelets, within its vasculature, predisposing to further leakage of gut flora and endotoxin into the circulation. 44 Such mechanisms could be subject to modulation by individual psychological factors that might influence the equilibrium of inflammatory mediators and set the course of who will survive and who will not.
Most patients who are pancytopenic become febrile, but only a minority will progress to organ failure and death. In their analysis of multiorgan failure after bone marrow transplantation, Gordon et al 45 showed that the pattern of albumin synthesis predicted an adverse prognosis. Hypoalbuminemia during inflammation is presumed to reflect cytokine action through which hepatic protein synthesis shifts from its normal pattern to produce 'acute phase' proteins. [46] [47] [48] This is consistent with subsequent evidence from Schots et al 49 showing that the level of C-reactive protein is also an early predictor of severe post-transplant complications and death. Although the initial serum albumin concentration did not differ among the FIT categories, subjects identified within the FIT 3/4 group tended to have a greater albumin deficit in the first month after transplant. Furthermore, those who maintained the deficit state also showed a trend to remain thrombocytopenic until death. Thus, the data suggest that psychological factors predicted not only death, but were also associated with metabolic and organ complications early in the post-transplant period. To prove a causal link between psychological and cytokine-mediated processes, further experiments must first demonstrate that different FIT parameters coexist with different responses to inflammatory stimuli. The possibilities that individuals who exhibit a life-long FIT 3/4 pattern might have a tendency toward immunologic dissonance, monocyte paralysis, or even a variant program for the control of their cytokine genes 50, 51 are all testable. Such a biological model rests upon the assumptions that psychological factors can influence biochemical reactions, that the primary psychological data were not epiphenomena of a transient physical state, and that underlying organ pathology did not generate the psychodynamic responses. Although the probability was (statistically) less than one in ten thousand that the association between survival and FIT category would have occurred by chance, alternate interpretations are possible. An occult physical lesion could conceivably predispose an individual to both exaggerated toxicity and a decompensated psychological state. We believe that this was not likely here, because the psychiatric data elicited in the psychodynamic interviews were not derived from subjective reports of the ambient mood, but were multifold. They included a condensation of the individual's life history of reaction to stress (defenses), the individual's pattern of interaction with other people and its influence on psychological functioning (object relations), and the individual's capacity to apply psychological resources to meet the challenge of a life-threatening procedure. Similarly, perceptions of a physically ill patient might unconsciously bias an interviewer to extract data that would lead to classification in a 'low' FIT category. Not only would that have surpassed the acumen of the treating physicians (assessment of performance status), it would have been more sensitive than known biochemical parameters, including the serum albumin concentration. However, formal exclusion of this possibility would require use of an objective instrument based upon essential components of the psychodynamic interview; development of this is in progress.
Another line of reasoning could suggest that individuals with a certain personality type might be more susceptible to complications, not as a result of a modified physiological response to a chemical toxin, but through detrimental behaviors. 52 We believe that this would not be a sufficient explanation for events in the first 4-8 weeks after a marrow transplant. During this period, clinical management depends minimally upon patient choice; ward routines prevail for monitoring vital signs, prescribing antibiotics, maintaining basal nutrition, and delivering circulatory support. As possible surrogates for 'seeking help', use of drugs to counter vomiting, diarrhea and anxiety was reviewed and found not to differ among individuals in the different FIT categories. A review of nurses' assessments did not reveal any trend toward non-compliance in any group. Indeed, patients in the higher FIT groups often tended to irritate the staff with their challenges to management decisions and demands to have questions answered, in contrast to the pseudo-compliance characteristic of the low FIT group. Even in the Canadian context, wherein someone in need of a bone marrow transplant is not challenged with a complex referral system, no doubt there exists an unmeasured element of self-selection. On occasion we have observed patients flee when confronted with the idea of a bone marrow transplant.
These observations raise issues relevant to clinical practice. First, the data do not justify health care providers to limit bone marrow transplantation to individuals with a 'correct' psychological profile. Although the FIT 3/4 personality might not be amenable to restructuring in the window of time accessible to cancer management, such individuals could possibly benefit from more intensive measures to manage sepsis (eg improved gut sterilization, wider coverage with prophylactic antibiotics, peripheral blood stem cell therapy with combinations of growth factors, cytokine primed granulocyte transfusions, agents aimed to modulate the cytokine response and redress immunologic dissonance). Second, stratification for psychological risk factors may improve the interpretation of clinical trials evaluating high-dose therapies or modulators of cytokine cascades. Finally, such a relationship could raise complex questions related to informed consent. Should an individual be told the results of their FIT status as part of their right to know and make an informed decision? Or is it mischief to follow existing ethical norms and risk the result of a self-fulfilling prophesy: 'My doctor says that I'm not going to make it (so I won't)'?
